Addition of the MUC-1 vaccine tecemotide to neoadjuvant systemic therapy for patients with early breast cancer: Survival results from the prospective randomized ABCSG 34 trial.Christian F. Singer, Michael Gnant, Angelika Pichler et al.|Journal of Clinical Oncology|2024Cited by 6
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34Stephanie Strobl, Martin Filipits, Christine Deutschmann et al.|The Breast|2025Cited by 1
Steckbrief ForschungTanja Zimmermann, Nina Rosa Neuendorff, Hubert Kübler et al.|Kompass Onkologie|2020Cited by 0